4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000009
PRESIDENT AND COO sold 22,500 shares at $417.50 ($9,393,671)
- PRESIDENT AND COO acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,625 | $135.42 | $1,980,518 | 14,625 | I |
| 2025-10-27 | Sale : show line 2 in the form 10b5-1 | −14,625 | $417.50 | $6,105,886 | 0 | I |
| 2025-10-27 | Exercise or conversion : show line 3 in the form 10b5-1 | +6,125 | $146.03 | $894,434 | 6,125 | I |
| 2025-10-27 | Exercise or conversion : show line 4 in the form 10b5-1 | +1,750 | $146.03 | $255,553 | 7,875 | I |
| 2025-10-27 | Sale : show line 5 in the form 10b5-1 | −7,875 | $417.50 | $3,287,785 | 130 | I |
| Open-market sales · 22,500 sh · avg $417.50 · $9,393,671 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-10-27 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Options | −14,625 | $135.42 | 2026-03-15 | 14,625 | 55,875 | I |
| 2025-10-27 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Options | −6,125 | $146.03 | 2026-03-15 | 6,125 | 18,375 | I |
| 2025-10-27 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Options | −1,750 | $146.03 | 2027-03-15 | 1,750 | 0 | I |
Loading xslF345X05/primarydocument.xml…